Teva shares approach 20-year low amid Moody's warning and other woes | Fierce Pharma
Teva Pharmaceuticals Near 20-Year Lows (NYSE:TEVA) | Seeking Alpha
The Horsham, Pa., offices of Teva Pharmaceuticals North America are shown Monday, July 25, 2005. In a deal that will create the world's largest generic drug company, Teva Pharmaceutical Industries Ltd. said
Teva Shares Progress Toward Access to Medicines and Environmental Commitments, Meeting and Exceeding Several ESG Targets Ahead of Schedule | Business Wire
Teva Stock: Teva Guides To Its First Year Of Growth Since 2017, But There's A Caveat | Investor's Business Daily
Teva profit plummets, stock slides | Ctech
Teva Pharmaceutical's Sales Slump 18% - WSJ
Teva's Share of the US Generics Market Could Boost Its Stock
Where Are Teva Shares Headed After the Q4 Decline?
Teva Pharmaceuticals Soars After Buffett's Berkshire Hathaway Discloses Stake
Teva Pharmaceutical: Slow Road To A Higher Share Price (NYSE:TEVA) | Seeking Alpha